An antiviral drug combination used to treat hepatitis C and an anti-protozoal drug may also work against SARS-CoV-2, researchers say.
An antiviral drug combination used to treat hepatitis C and an anti-protozoal drug may also work against SARS-CoV-2, researchers say.